Novartis Price Prediction and Hype Density Breakdown

NVS -- USA Stock  

USD 84.44  0.53  0.63%

We analyze noise-free headlines and recent hype associated with Novartis AG which may create opportunities for some arbitrage if properly timed. With Novartis hype-based prediction module you can estimate the value of Novartis AG from the prospective of Novartis response to recently generated media hype and the effects of current headlines on its competitors. The module also provides analysis of price elasticity to changes in media outlook on Novartis over a specific investment horizon. Please see also Novartis Basic Forecasting Models to cross-verify your projections.
Horizon     30 Days    Login   to change

Novartis After-Hype Price Density Analysis

 Next price density 
      Expected price to next headline 

Novartis Estimiated After-Hype Price Volatility

May 24, 2019
Current Value
After-hype Price
Novartis is very steady asset. Analysis and calculation of next after-hype price of Novartis AG is based on 2 months time horizon.

Novartis Next Price Analysis

Daily Expected returnPeriod VolatilityHype elasticityRelated hype elasticityAverage news densityRelated news densityNext Expected Hype
 0.20% 2.37% 0.19%  0.02% 6 Events / Month5 Events / MonthIn about 6 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility

Novartis Hype Timeline

On 24 of May Novartis AG is traded for 84.44. The entity has historical hype elasticity of -0.19 and average elasticity to hype of competition of 0.02. Novartis AG is estimated to decline in value after the next headline with price expected to drop to 84.25. The average volatility of media hype impact on the company stock price is about 254.84%. The closing price depreciation on the next news is expected to be -0.23% where as daily expected return is now at -0.2%. The volatility of related hype on Novartis is about 2548.39% with expected price after next announcement by competition of 84.46. The book value of the company was now reported as 20.33. The company has Price/Earnings To Growth (PEG) ratio of 2.39. Novartis AG recorded earning per share (EPS) of 5.27. The entity last dividend was issued on 2019-03-04. The firm had 2:1 split on 2019-04-09. Considering 30-days investment horizon, the next estimated press release will be in about 6 days.
Please see also Novartis Basic Forecasting Models to cross-verify your projections.

Novartis Related Hype Analysis

At Risk
AstraZeneca PLC 0.03 9 per month 0.00 (0.15)  1.93 (2.62)  6.85 
Bristol Myers Squibb Company 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
GlaxoSmithKline plc(0.21) 6 per month 0.00 (0.09)  1.36 (1.08)  4.00 
Hutchison China MediTech Limited 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
Johnson Johnson 1.00 8 per month 0.62  0.07  1.10 (1.11)  2.99 
Eli Lilly and Company 0.43 9 per month 0.00 (0.18)  1.39 (2.14)  4.54 
Merck Co 0.46 8 per month 0.00 (0.0235)  2.04 (1.88)  5.61 
Novartis AG(0.93) 6 per month 0.00 (0.09)  1.83 (2.00)  13.97 
Pfizer 0.15 8 per month 1.20  0.0077  1.21 (1.97)  4.55 
GW Pharmaceuticals plc 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
Please see also Novartis Basic Forecasting Models to cross-verify your projections. Please also try Companies Directory module to evaluate performance of over 100,000 stocks, funds, and etfs against different fundamentals.